FDA more cautious on new drug decisions (The Journal News)
Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data.

IsoTis Receives FDA Clearance for Accell Family of Products (CNW Group via Yahoo! Finance)
IsoTis, Inc. , an orthobiologics company, today announced that it received a letter dated August 15, 2007 from the US Food and Drug Administration , clearing the Accell Family of Products for marketing in the US as Class II medical devices.